Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
21.82
1.52 (7.49%)
At close: Aug 15, 2025, 3:59 PM
21.76
-0.30%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sarepta Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 510.6M | 240.87M | 1.1B | 197.85M | 383.62M | 427.29M | 428.43M | 541.93M | 851.93M | 871.67M | 966.78M | 1.04B | 868.57M | 1.23B | 2.12B | 1.6B | 1.7B | 1.48B |
Short-Term Investments | 289.54M | 281.89M | 251.78M | 1B | 1.08B | 963.45M | 1.25B | 1.19B | 1.01B | 1.01B | 1.02B | 1.03B | 1.06B | 779.55M | n/a | n/a | 30M | 256M |
Long-Term Investments | 245.71M | 109.13M | 133.16M | 181.77M | 23.18M | 41.38M | 22.11M | 13.45M | 31M | 31M | 31.32M | 33.24M | 33.23M | 33.39M | 34.89M | 35.29M | 39.97M | 40.64M |
Other Long-Term Assets | 231.7M | 389.88M | 241.01M | 286.11M | 288.98M | 298.06M | 276.41M | 199.03M | 194.98M | 288.33M | 286.62M | 259.88M | 250.97M | 245.25M | 143.28M | 12.79M | 12.73M | 12.41M |
Receivables | 609.6M | 724.52M | 649.73M | 515.99M | 392.26M | 419.38M | 439.71M | 354.26M | 267.16M | 288.08M | 259.7M | 223.45M | 230.28M | 197.2M | 171.64M | 178.87M | 145.21M | 133.31M |
Inventory | 994.04M | 941.43M | 749.96M | 565.92M | 485.8M | 373.53M | 322.86M | 244.01M | 226.88M | 202.68M | 203.97M | 221.19M | 208.09M | 199M | 186.21M | 288.47M | 268.76M | 240.33M |
Other Current Assets | 218.96M | 7.99M | 9.21M | 52.47M | 310.87M | 246.9M | 110.36M | 90.79M | 90.47M | 86.8M | 78.49M | 83.41M | 79.31M | 95.1M | 100.07M | 94.24M | 96.66M | 127.02M |
Total Current Assets | 2.66B | 2.43B | 3.07B | 2.69B | 2.68B | 2.46B | 2.58B | 2.45B | 2.47B | 2.49B | 2.56B | 2.63B | 2.47B | 2.53B | 2.6B | 2.19B | 2.27B | 2.27B |
Property-Plant & Equipment | 514.9M | 507.65M | 488.65M | 446.69M | 400.2M | 375.57M | 357.11M | 345.82M | 323.6M | 244.88M | 244.99M | 224.04M | 230.29M | 233.23M | 236.69M | 271.91M | 276.2M | 268.18M |
Goodwill & Intangibles | 30.52M | 26.2M | 26.89M | 27.57M | 28.25M | 28.93M | 29.62M | 19.5M | 18.02M | 7.2M | 7.58M | 13.06M | 13.06M | 13.33M | 14.24M | 14.2M | 14.11M | 14.12M |
Total Long-Term Assets | 1.02B | 1.03B | 889.71M | 914.57M | 740.62M | 759.52M | 685.25M | 658.86M | 653.28M | 571.41M | 570.5M | 530.22M | 527.55M | 525.21M | 543.88M | 476.91M | 493.86M | 493.88M |
Total Assets | 3.68B | 3.47B | 3.96B | 3.6B | 3.42B | 3.22B | 3.26B | 3.11B | 3.13B | 3.06B | 3.13B | 3.16B | 3B | 3.06B | 3.15B | 2.66B | 2.76B | 2.77B |
Account Payables | 136.7M | 156.1M | 214.44M | 118.77M | 107.42M | 91.54M | 164.92M | 87.95M | 109.8M | 106.71M | 95.88M | 118.46M | 56.21M | 54.01M | 76.74M | 44.16M | 76.68M | 76.65M |
Deferred Revenue | 395.43M | 44.86M | 130.26M | 127M | 122.04M | 112M | 50.42M | 22.49M | 44.99M | 67.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M | 89.24M |
Short-Term Debt | n/a | n/a | n/a | 91.59M | 91.5M | 105.59M | 123.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 313.85M | 166.62M | 278.48M | 362.12M | 299.32M | 249.18M | 218.42M | 264.48M | 278.15M | 318.99M | 340.53M | 348.43M | 365.44M | 292.53M | 125.5M | 210.31M | 227.88M | 175.32M |
Total Current Liabilities | 919.95M | 605.59M | 731.68M | 699.49M | 688.49M | 608.71M | 653.66M | 450.74M | 498.65M | 536.88M | 619.6M | 602.92M | 545.57M | 454.96M | 452.73M | 373.44M | 425.02M | 364.74M |
Long-Term Debt | 1.14B | 1.14B | 1.14B | 1.14B | 1.13B | 1.13B | 1.13B | 1.24B | 1.24B | 1.23B | 1.54B | 1.54B | 1.1B | 1.1B | 1.1B | 1.09B | 1.09B | 1.09B |
Other Long-Term Liabilities | 48.6M | 48.33M | 49.15M | 373.4M | 55.29M | 55.72M | 41.1M | 38.1M | 36.14M | 36.94M | 36.94M | 36.9M | 54.6M | 54.6M | 54.6M | 64.17M | 71.44M | 71.78M |
Total Long-Term Liabilities | 1.4B | 1.72B | 1.7B | 1.68B | 1.66B | 1.65B | 1.75B | 1.89B | 1.89B | 1.81B | 2.12B | 2.12B | 1.72B | 1.74B | 1.77B | 1.82B | 1.85B | 1.87B |
Total Liabilities | 2.32B | 2.32B | 2.44B | 2.38B | 2.35B | 2.26B | 2.41B | 2.35B | 2.38B | 2.35B | 2.74B | 2.73B | 2.27B | 2.2B | 2.22B | 2.19B | 2.27B | 2.23B |
Total Debt | 1.35B | 1.34B | 1.34B | 1.4B | 1.37B | 1.38B | 1.4B | 1.37B | 1.36B | 1.29B | 1.62B | 1.58B | 1.14B | 1.14B | 1.14B | 1.16B | 1.16B | 1.15B |
Common Stock | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 8K |
Retained Earnings | -4.46B | -4.66B | -4.21B | -4.37B | -4.4B | -4.41B | -4.45B | -4.49B | -4.45B | -4.43B | -3.91B | -3.8B | -3.54B | -3.31B | -3.21B | -3.08B | -3.04B | -2.96B |
Comprehensive Income | -51K | 34K | -218K | 2.25M | -1.03M | -691K | 918K | -638K | -1.05M | -419K | -1.66M | -3.21M | -2.48M | -306K | -20K | -20K | 2K | -3K |
Shareholders Equity | 1.36B | 1.14B | 1.53B | 1.22B | 1.08B | 961.19M | 859.34M | 764.36M | 741.41M | 712.75M | 384.95M | 430.84M | 726.46M | 856.89M | 928.01M | 469.53M | 485.11M | 535.45M |
Total Investments | 535.25M | 391.02M | 384.94M | 1.18B | 1.1B | 963.45M | 1.27B | 1.19B | 1.01B | 1.01B | 1.05B | 1.07B | 1.09B | 812.94M | 34.89M | 35.29M | 69.97M | 296.64M |